Memorial Antalya Hospital
Memorial Antalya Hospital is JCI-accredited, ensuring international quality and safety standards. The hospital treats 1,600,000 patients annually and offers comprehensive oncology services. Its oncology center follows NCCN and ESMO protocols for immunotherapy with Keytruda (pembrolizumab). Situated 6 km from the sea, patients can enjoy Antalya's sights. The hospital provides interpreter services and free airport transfers, making it convenient for international patients. Memorial Antalya Hospital is a top choice for immunotherapy treatments in Turkey.